Asia regional support letter for inclusion of Daclatasvir in WHO Model list of Essential Medicines
March 4, 2015 – Regional advocacy platform for access to Hep C treatment in Asia Pacific wrote to The Secretary of the 20th Expert Committee on the Selection and Use of Essential Medicines supporting MSF’s application to include Daclatasvir in the Model List of Essential Medicines of the World Health Organisation (WHO)…read full letter